- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05955534
Concomitant Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy (TPUG)
A Multicenter, Randomized Controlled Trial of Concomitant Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Richard Gentry Wilkerson, M.D.
- Phone Number: 410-328-4237
- Email: gwilkerson@som.umaryland.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical Systems
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informed consent must be obtained from the participant or a Legally Authorized Representative before any trial-specific assessment is performed
- Male or female ≥ 18 years of age
- Participants with Ventilator Dependent Respiratory Failure (VDRF)
- Indication for a bedside percutaneous tracheostomy procedure using an FDA approved percutaneous dilatational tracheostomy device
- Indication for percutaneous gastrostomy including Percutaneous Ultrasound (PUG), Percutaneous Radiologic (PRG), and Percutaneous Endoscopic Gastrostomy (PEG) using an FDA approved gastrostomy kit
- No contraindications to bedside percutaneous tracheostomy OR gastrostomy
- Women of childbearing potential must have negative serum or urine pregnancy test during the current hospitalization
Exclusion Criteria:
- History of prior gastrostomy, tracheostomy, laryngectomy, gastrostomy prior to tracheostomy decision, known head and neck and gastrointestinal abnormality (cancer, congenital abnormality, anatomic variants).
- Hospitalization > 21 days at the time of screening
- Known social discharge issues that in the opinion of the investigator will substantially impact the LOS.
- Participants with non-survivable injuries or disease, anticipated life expectancy < 30 days.
- Uncontrolled coagulopathy
- Contraindications for percutaneous gastrostomy procedures
- Severe Ascites
- Abdominal wall infection at selected site of procedure
- Severe gastroparesis
- Gastric outlet obstruction
- Absolute contraindications to percutaneous dilatational tracheostomy procedure
- Cervical instability
- Infection at the planned insertion site
- Relative contraindications to percutaneous dilatational tracheostomy deemed present by the clinical team
- Difficult anatomy (e.g., short neck, morbid obesity, minimal next extension, or tracheal deviation)
- Severe respiratory disease resulting in inability to withstand periods of apnea or in the loss of positive pressure ventilation
- Pregnancy
- Incongruent goals of care between care team and LAR (family representative).
- Other procedure related concerns by the primary team that would affect safety of the patient.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Group
The control group will receive percutaneous bedside tracheostomy along with gastrostomy methods other than PUG, including but not limited to Percutaneous Endoscopic or Radiologic Gastrostomy (PEG or PRG, respectively), or surgical gastrostomy.
|
Each site will perform the procedures of gastrostomy placement using the devices according to their institutional policy and guidelines.
Other Names:
Each site will perform the procedures of gastrostomy placement using the devices according to their institutional policy and guidelines.
Other Names:
|
Experimental: Intervention Group (TPUG)
The intervention group will receive concomitant percutaneous bedside tracheostomy and PUG.
|
Tracheostomy shall utilize any FDA approved device for the performance of percutaneous dilatational tracheostomy.
PUG shall be performed using the only FDA-cleared device for ultrasound gastrostomy, the PUMA-G System.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of stay in ICU
Time Frame: ICU discharge - up to 24 weeks
|
To compare the ICU (Intensive Care Unit) length of stay (days) from the time the decision is made to place a tracheostomy tube and gastrostomy tube to the time of discharge from the ICU for participants receiving TPUG versus a control group.
|
ICU discharge - up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of hospital stay
Time Frame: Hospital discharge - through study completion, an average of 45 days
|
To compare the hospital length of stay (days) and total hospital costs (United States Dollars) from the time the decision is made to place a tracheostomy tube and gastrostomy tube to the time of discharge from the hospital for participants receiving TPUG versus a control group.
|
Hospital discharge - through study completion, an average of 45 days
|
Demographics
Time Frame: End of study comparison - through study completion, an average of 45 days
|
To assess confounding variables and differences between groups that could affect outcomes:
|
End of study comparison - through study completion, an average of 45 days
|
Collaborators and Investigators
Investigators
- Study Chair: Dana Beach, RN, University of Maryland, Baltimore
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HP-00104764
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The Principal Investigator will centrally aggregate and maintain screening and recruitment information from all study sites and routinely inform and share this data with the entire study team in a deidentified fashion. The principal investigator and co-investigators will maintain a personal participant identification list (participant numbers with the corresponding participant names) to enable records to be identified.
The University of Maryland School of Medicine's research team will ensure that all study-related documents are collected and maintained.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
Clinical Trials on PEG
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Renmin Hospital of Wuhan UniversityHubei Hospital of Traditional Chinese Medicine; Wuhan Central Hospital; The Third... and other collaboratorsCompletedBowel Preparation Before ColonoscopyChina
-
Inje UniversityCompletedColonoscopy | Bowel PreparationKorea, Republic of
-
Changchun GeneScience Pharmaceutical Co., Ltd.Not yet recruitingPediatric Growth Hormone Deficiency (PGHD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedColonoscopy | Bowel Preparation | Hospitalized PatientsItaly
-
Beijing Ditan HospitalBeijing YouAn Hospital; Beijing 302 Hospital/5th Medical Center of Chinese...Recruiting
-
Devirex AGTerminatedGenital HerpesSwitzerland
-
Air Force Military Medical University, ChinaUnknown